How big is our practice group?
92 lawyers and technical advisors (18 partners, 34 associates and 40 technical advisors).

Christine Santariga (Boston College Law School '06), works on IP transactions that include licensing, services, outsourcing, and strategic agreements. She also advises clients on a wide variety of privacy and information security compliance issues. She is a Certified Information Privacy Professional (CIPP) and a member of the International Association of Privacy Professionals.

Megan Baca (Harvard Law School '07) focuses primarily on intellectual property transactions in the technology and life sciences industries. Her practice includes a mix of general corporate work and intellectual property matters, including licensing transactions, mergers and acquisitions, and commercial transaction. She also is a member of the data privacy and security group and the life sciences group.

What we do?
The Intellectual Property Group represents clients for whom intellectual property is an important asset in the operation of their business. In addition to helping our clients complete transactions involving intellectual property, we also help our clients procure, manage, and defend intellectual property rights, including by prosecuting trademarks and patents. Our practice is primarily centered on five areas: engineering sciences; life sciences; trademarks and brand management; media and publishing; and data and privacy. The group's engineering sciences IP practice focuses on assisting clients involved in developing and marketing advanced technologies developed within the fields of electrical, optical, and mechanical engineering. Our life sciences IP practice represents the firm's life sciences clients in various biological and chemical discovery areas.

Our corporate patent practice, which has 12 partners and 62 associates and technical advisors, helps our clients by designing patent portfolios that enhance the ability of our clients to reach their business goals, evaluating patent validity, infringement and enforceability; preparing and prosecuting patent applications; handling adversarial proceedings involving U.S. and foreign prosecution matters, assisting in patent licensing transactions; and explaining the implications of recently proposed and enacted patent legislation around the world to our clients.

In the area of trademarks and brand management, we provide comprehensive services, from mark clearance to registration, portfolio management, advertising compliance, and enforcement litigation.

In our media and publishing practice we represent clients who create, manage and exploit media properties in both traditional and news media.

Finally, in our data and privacy practice, we help our data industry clients build and manage businesses that comply with the ever-expanding privacy regulations in the United States and abroad. We also help other clients assess and minimize risk involving data.

Michael Chasan (Fordham Law School '07) joined the firm as a technical advisor in 2002. Since graduating from Fordham in 2007, Michael has continued at the firm as an associate practicing in the Intellectual Property & Rights Management department.  His practice includes drafting and prosecuting patent applications in the areas of electrical engineering, computer science, medical devices, and business methods.  His practice also includes performing assessments of intellectual property in connection with portfolio development, corporate transactions and pre-suit investigations.  Michael received his B.S.E. and M.S.E. in electrical engineering from the University of Pennsylvania.  Michael works in our New York office.

Christopher Carroll (Suffolk University Law School '03), who is an inventor for three U.S. Patents and is registered to practice before the U.S. Patent and Trademarks Office, routinely drafts patent applications for the firm's technology clients and advises on other intellectual property and technology issues. Chris has a B.S. in electrical engineering and an M.S. in computer engineering. He previously worked as an engineer in the telecommunications industry.

Technical Advisor Program: In addition to hiring our associate lawyers from law schools, the firm hires scientists after their graduate training to work as technical advisors in our Intellectual Property Group. Technical advisors work at the firm while attending law school. Some attend school days and others at night. Technical advisors generally become associates at the firm after their law school training is complete. They are eligible to receive seniority credit for the time spent as a technical advisor. If interested in applying for a position in this program, please submit your resume materials to:

Christina Meincke
Legal Recruiting Coordinator
1211 Avenue of the Americas
New York, NY
10036-8704
E-Mail: hiringprogram@ropesgray.com

Four of our technical advisors and a former technical advisor who recently became an associate are profiled below:

Tushar Parlikar joined Ropes & Gray in 2007 after completing his Ph.D. in Electrical Engineering at MIT. He is currently a Patent Agent in the IP/Corporate group. Tushar has co-authored several peer-reviewed technical papers and is a co-inventor on a U.S. patent and several U.S. patent applications. In the past few years, Tushar has gained experience in preparing and prosecuting patent applications for a wide range of technologies. Tushar says that working at Ropes & Gray has been "intellectually challenging and exciting", and that the "experience he's gained in managing client expectations" and "working with top-notch IP attorneys" is "invaluable".

Alla Brukman (New York University School of Law '10 (expected)) is a registered patent agent working in our New York office.  Alla works on the preparation and worldwide prosecution of patent applications in the fields of pharmaceuticals and biotechnology, as well as freedom to operate opinions and assessments of intellectual property portfolios.  Alla joined the firm in 2006 after completing her Ph.D. in Molecular Biology at Princeton University.  Alla's Ph.D. research focused on the interaction of an animal alphaherpesvirus with the host innate immune response.

Min Park is a registered patent agent with Ropes & Gray's Intellectual Property Group. Since joining the firm in 2007, she has worked on the preparation and prosecution of patent applications and patentability, invalidity, and freedom to operate opinions relating to medical and mechanical devices. Prior to joining Ropes & Gray, Min previously worked as a product development engineer for Biomet Trauma, where she developed implants and instrumentation for the treatment of fractures of the femur. Min received her B.S. in Biological engineering and Masters of Engineering in Mechanical engineering from Cornell University.

Mimi Lee joined the firm as a technical advisor in 2006. Mimi works on the preparation and worldwide prosecution of patent applications relating to biology, biotechnology and pharmaceuticals. Mimi received her Ph.D. in neurobiology from MIT in 2006 and currently works in our New York office.

Gall Gotfried is a registered patent agent with Ropes & Gray's Intellectual Property Group. Since joining the firm in 2005, he has worked on the preparation and prosecution of patent applications and patentability, invalidity, freedom to operate opinions, and has provided assistance in patent assertion and litigation. Gall has graduated law school from New York Law School in 2010 and after receiving his Masters in Computer and Electrical Engineering from Carnegie Mellon University.

• Represented a consortium of private equity firms, including Bain Capital and Catterton Partners, in its $3.2 billion acquisition of OSI Restaurant Partners, Inc., a casual dining restaurant company whose portfolio of brands includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill, Fleming's Prime Steakhouse & Wine Bar, Roy's, Lee Roy Selmon's, Cheeseburger in Paradise and Blue Coral Seafood & Spirits. Intellectual property due diligence and evaluation, particularly with respect to the company's brands, played a key role in this transaction. For a description of an associate's role in this transaction, click here.
• Represent Rovi Corporation in connection with prosecuting and managing its significant patent portfolio and litigating patent disputes in which it is involved. Rovi Corporation is a leading, global media and technology company that develops, licenses, markets and distributes products and services that simplify and enhance television guidance and consumer entertainment. For a description of the associate's role on these matters, click here. 
• Represent Biogen in the global management and production of their IP rights in their number 1 product, Avonex®, on the treatment of multiple sclerosis.
• Represented Medtronic in the $1.35 billion acquisition of the medical device patent portfolio of a prolific inventor in settlement of ongoing patent litigation between the parties. This transaction required an integrated team of patent prosecution, litigation, licensing and mergers and acquisitions expertise drawn from three of our offices to structure and negotiate a complex acquisition.
• Assisted EMC, the leading data storage company, with a series of corporate acquisitions and investments, helping them to incorporate the latest technology and software into their storage products, and advising them on a wide range of intellectual property issues.
• Represented Genzyme Corporation in the acquisition of worldwide rights to three drugs used in the treatment of cancer. For a description of the associate's role on these matters, click here. 
• Represent Simmons in connection with global brand licenses and brand management for Simmons mattresses, including a portfolio of active registered trademarks, and acquisition of new product lines.
• Represented Genzyme Corporation in connection with a license and product agreement related to antisense therapy for the treatment of high cholesterol.
• Represent Vertex Pharmaceuticals in coordinating and designing its patent portfolio worldwide. Some of Vertex’s patents related to HIV-drugs, which are now on the market. Other patents related to Hepatitis C virus drugs, now in clinical testing.
• Represented Bayer Health Care in a $225 million co-development and commercialization agreement with Nektar Therapeutics to commercialize NKTR-061, a drug that will be usedto treat Gram-negative pneumonias. Under the terms of the agreement, Bayer is responsible for global clinical development, regulatory strategy, manufacturing and marketing of NKTR-061. Nektar received $50 million upfront payment and will receive $175 million in milestonepayments with successful development and commercialization of NKTR-061.